Xylazine bill protects DVMs’ access to sedative, AVMA says
Language within the SUPPORT Act will schedule xylazine as a Schedule III drug, but allow continued use of the FDA-approved animal drug by veterinarians
Pain management
Pain management integral to pet health
Helping veterinary professionals qualify and treat pain in companion animals is the goal of a new certificate launched by the World Small Animal Veterinary Association (WSAVA).
Canine OA injectable gets green light
Dogs afflicted with osteoarthritis (OA) pain can soon benefit from a novel treatment.